22494505|t|Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.
22494505|a|BACKGROUND: Glutathione S-transferase omega-1 and 2 genes (GSTO1, GSTO2), residing within an Alzheimer and Parkinson disease (AD and PD) linkage region, have diverse functions including mitigation of oxidative stress and may underlie the pathophysiology of both diseases. GSTO polymorphisms were previously reported to associate with risk and age-at-onset of these diseases, although inconsistent follow-up study designs make interpretation of results difficult. We assessed two previously reported SNPs, GSTO1 rs4925 and GSTO2 rs156697, in AD (3,493 ADs vs. 4,617 controls) and PD (678 PDs vs. 712 controls) for association with disease risk (case-controls), age-at-diagnosis (cases) and brain gene expression levels (autopsied subjects). RESULTS: We found that rs156697 minor allele associates with significantly increased risk (odds ratio = 1.14, p = 0.038) in the older ADs with age-at-diagnosis > 80 years. The minor allele of GSTO1 rs4925 associates with decreased risk in familial PD (odds ratio = 0.78, p = 0.034). There was no other association with disease risk or age-at-diagnosis. The minor alleles of both GSTO SNPs associate with lower brain levels of GSTO2 (p = 4.7 x 10-11-1.9 x 10-27), but not GSTO1. Pathway analysis of significant genes in our brain expression GWAS, identified significant enrichment for glutathione metabolism genes (p = 0.003). CONCLUSION: These results suggest that GSTO locus variants may lower brain GSTO2 levels and consequently confer AD risk in older age. Other glutathione metabolism genes should be assessed for their effects on AD and other chronic, neurologic diseases.
22494505	41	72	Alzheimer and Parkinson disease	Disease	MESH:D010300
22494505	187	226	Glutathione S-transferase omega-1 and 2	Gene	9446;119391
22494505	234	239	GSTO1	Gene	9446
22494505	241	246	GSTO2	Gene	119391
22494505	268	299	Alzheimer and Parkinson disease	Disease	MESH:D010300
22494505	301	303	AD	Disease	MESH:D000544
22494505	308	310	PD	Disease	MESH:D010300
22494505	680	685	GSTO1	Gene	9446
22494505	686	692	rs4925	SNP	tmVar:rs4925;VariantGroup:1;CorrespondingGene:9446;RS#:4925;CorrespondingSpecies:9606
22494505	697	702	GSTO2	Gene	119391
22494505	703	711	rs156697	SNP	tmVar:rs156697;VariantGroup:0;CorrespondingGene:119391;RS#:156697;CorrespondingSpecies:9606
22494505	716	718	AD	Disease	MESH:D000544
22494505	726	729	ADs	Disease	
22494505	754	756	PD	Disease	MESH:D010300
22494505	762	765	PDs	Disease	
22494505	938	946	rs156697	SNP	tmVar:rs156697;VariantGroup:0;CorrespondingGene:119391;RS#:156697;CorrespondingSpecies:9606
22494505	1049	1052	ADs	Disease	
22494505	1107	1112	GSTO1	Gene	9446
22494505	1113	1119	rs4925	SNP	tmVar:rs4925;VariantGroup:1;CorrespondingGene:9446;RS#:4925;CorrespondingSpecies:9606
22494505	1163	1165	PD	Disease	MESH:D010300
22494505	1341	1346	GSTO2	Gene	119391
22494505	1386	1391	GSTO1	Gene	9446
22494505	1499	1510	glutathione	Chemical	MESH:D005978
22494505	1616	1621	GSTO2	Gene	119391
22494505	1653	1655	AD	Disease	MESH:D000544
22494505	1681	1692	glutathione	Chemical	MESH:D005978
22494505	1750	1752	AD	Disease	MESH:D000544
22494505	1772	1791	neurologic diseases	Disease	MESH:D020271
22494505	Negative_Correlation	MESH:D010300	RS#:4925;CorrespondingGene:9446
22494505	Association	MESH:D005978	MESH:D020271
22494505	Association	MESH:D010300	119391
22494505	Association	MESH:D000544	119391
22494505	Association	MESH:D010300	9446
22494505	Association	MESH:D010300	9446

